Trial Profile
Does Galvus enhance the effects of a protein preload to reduce postprandial glycemia in patients with type 2 diabetes?
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Whey protein concentrate (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Sep 2012 New trial record